Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients.

@article{Selzner2011ImmunemediatedCO,
  title={Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients.},
  author={Nazia Selzner and Maha M. Guindi and Eberhard Ludwig Renner and Marina Berenguer},
  journal={Journal of hepatology},
  year={2011},
  volume={55 1},
  pages={207-17}
}
Hepatitis C virus (HCV) re-infection of the graft is universal and interferon based antiviral therapy remains at present the treatment of choice in HCV liver transplant recipients. Apart from the antiviral effects, interferon and ribavirin have both potent immunomodulatory properties resulting in a broad range of immune-related disorders including acute cellular rejection and chronic ductopenic rejection as well as de novo autoimmune hepatitis. Further complicating the picture, HCV infection… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 90 references

: case - control study showing poor outcome and predictive features in the liver explant

  • S Berardi, F Lodato, A Gramenzi, A D’Errico, M Lenzi, A Bontadini
  • 2009

: predictors of response and long - term outcome

  • CS Wang, HH Ko, EM Yoshida, CA Marra, K Richardson
  • 2009

Similar Papers

Loading similar papers…